Details for 2018747362

Up to date per 03.04.2026

Actions

Title / Product Name

TGF-BETA- UND ACTRII-ANTAGONISTEN ZUR BEHANDLUNG VON LEUKÄMIE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018747362

EP Publication Number

3576773

E-Number

1621842

Language

PCT Number

US18016148

Publication Date

11.12.2019 A

18.10.2023 B1

Registration Date

18.10.2023

AT Publication Date

15.11.2023

Application Date

31.01.2018

Registration Number

Priorities

01.02.2017

201762453413 P

IPC

A61K 38/17 20060101AFI20200706BHEP

Maximum Duration of Protection

31.01.2038

Owner

Acceleron Pharma Inc.128 Sidney Street Cambridge, MA 02139US

Representative

No representatives present

Inventor

PEARSALL, Robert Scott8 Winterberry Lane North Reading, MA 01864US

KUMAR, Ravindra421 Arlington Street Acton, MA 01720US